Opinion
News-Medical.Net on MSNOpinion
Study on inhaler overuse highlights urgent need for better objective asthma monitoring
Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
Please provide your email address to receive an email when new articles are posted on . Use of reliever inhalers went up on days with unhealthy air quality levels around the time of the Canadian ...
Please provide your email address to receive an email when new articles are posted on . Data were derived from Mosnaim GM, et al. Abstract 488. Presented at: AAAAI Annual Meeting; Feb. 24-27, 2023; ...
Health on MSN
What To Know about Asthma Attacks
An asthma attack makes breathing hard, and it can be triggered by allergens or intense emotions. It is important to use a ...
For asthma sufferers, the rush for breathing relief often makes for incorrect use of inhalers. The wrong technique can make the disease worse in the long run. During an asthma attack, sufferers still ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...
Add Yahoo as a preferred source to see more of our stories on Google. Children who use a lot of blue reliever inhalers are several times more likely to have severe asthma attacks [BBC] A new study is ...
Medics have warned that some asthma sufferers using blue inhalers could be putting their health at risk. More than seven million Brits are living with asthma, according to Asthma and Lung UK. An ...
Active ingredient: Ciclesonide 80 µg/inhalation, 160 µg/inhalation; metered-dose inhaler. Indication: Maintenance treatment of asthma as prophylactic therapy in patients >12 years of age. Pharmacology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results